Urinary albumin excretion: An independent predictor of ischemic heart disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 8, 1999, Pages 1992-1997

  Borch Johnsen, Knut ^a,d   Feldt Rasmussen, Bo ^b   Strandgaard, Svend ^c   Schroll, Marianne ^a   Jensen, Jan Skov ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d STENO DIABETES CENTER   (Denmark)

Author keywords

Atherosclerosis; Ischemic heart disease; Microalbuminuria; Urinary albumin excretion

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ARTICLE; BODY MASS; CREATININE URINE LEVEL; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; URINARY EXCRETION;

EID: 0032769548     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.8.1992     Document Type: Article

References (54)

1. Jensen T, Stender S, Decker T. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia. 1988;31:142-145.
2. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Voutilainen E, Penttila I, Pyorala K. Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1990;33:237-243.
3. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrels TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med. 1984;1:17-19.
4. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310:356-360.
5. Rossing P, Hougaard P, Borch-Johnsen K, Parving H-H. Predictors of mortality in insulin dependent diabetes: 10 year observational follow-up study. BMJ. 1996;313:779-784.
6. Decken T, Yokoyama H, Mathiesen E, Ronn B, Jensen T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen JS. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ. 1996;312:871-874.
7. Damsgaard EM, Frøland A, Jørgensen OD. Mogensen CE. Eight to nine year mortality in known non-insulin dependent diabetes and controls. Kidney Int. 1992;41:731-735.
8. Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes: a 10-year follow-up study of 503 patients. Diabet Med. 1988;5:1126-1134.
9. Torffvit O, Agardh C-D. The predictive value of albuminuria for cardiovascular and renal disease: a 5-year follow-up study of 476 patients with type 1 diabetes mellitus. J Diabetes Complications. 1993;7:49-56.
10. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 1992;41:736-741.
11. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 1995;44:1303-1309.
12. Beilin J, Stanton KG, McCann VJ, Knuiman MW, Divitini ML. Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality. Aust N Z J Med. 1996;26:519-525.
13. Winocour PH, Harland JOE, Millar JP, Laker MF, Alberti KGMM. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis. 1992;93:71-81.
14. Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP. Microalbuminuria: associations with height and sex in non-diabetic subjects. BMJ. 1993;306:240-242.
15. Woo J, Cockram CS, Swaminathan R, Lau E, Chan A, Cheung R. Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects. Int J Cardiol. 1992;37:345-350.
16. Dimmitt SB, Lindquist TL, Mamotte CDS, Burke V, Beilin LJ. Urine albumin excretion in healthy subjects. J Hum Hypertens. 1993;7: 239-243.
17. Haffner SM, Stern MB, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria: potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis. 1990;10:727-731.
18. Gosling P, Beevers DG. Urinary albumin excretion and blood pressure in the general population. Clin Sci. 1989;76:39-42.
19. Metcalf PA, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in people at least 40 years old: effect of obesity, hypertension and hyperlipidemia. Clin Chem. 1992;38:1802-1808.
20. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis. 1995;112:245-252.
21. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci. 1995;88:629-633.
22. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia. 1989;32:219-226.
23. Jensen JS. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1324-1329.
24. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
25. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Hyperinsulinemic microalbuminuria: a new risk indicator of coronary heart disease. Circulation. 1995;91:831-837.
26. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G, the Copenhagen City Heart Study Group. Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects. Scand J Clin Lab Invest. 1993;53:867-872.
27. Jensen JS, Borch-Johnsen K, Feldt-Rasmussen B, Appleyard M, Jensen G. Urinary albumin excretion and history of acute myocardial infarction in a cross-sectional population study of 2,613 individuals. J Cardiovasc Risk. 1997;4:121-125.
28. Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP. Associations of urinary albumin excretion rate with vascular disease in Europid nondiabetic subjects. J Diabetes Complications. 1994;8: 180-188.
29. Dobson AJ, Evans A, Ferrario M, Kuulasmaa KA, Moltchanov VA, Sans S, Tunstall-Pedoe H, Tuomilehto J, Wedel H, Yarnell J. Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA project. Ann Med. 1998;30:199-205.
30. Jørgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol 1987;126:912-921.
31. Schroll M. The World Health Organization Monica Project: a major international collaboration. J Clin Epidemiol. 1988;41:105-114.
32. Feldt-Rasmussen B, Dinesen B, Decken M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest. 1985;45:539-544.
33. Larsen K. Creatinine assay by a reaction kinetic principle. Clin Chim Acta. 1972;45:209-217.
34. Mogensen CE. Frontiers in medicine: systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Intern Med. 1994;235:297-316.
35. World Health Organisation. International Classification of Diseases (ICD-8). 8th rev. Geneva, Switzerland: World Health Organisation; 1967.
36. Nyboe J, Jensen G, Appleyard M, Schnohr P. Risk factors for acute myocardial infarction in Copenhagen, I: hereditary, educational and socioeconomic factors. Eur Heart J. 1989;10:910-916.
37. Mosbech J, Jørgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen TD. Landspatientregisteret: evaluering af datakvaliteten. [The National Hospital Discharge Register: evaluation of the data quality]. Ugeskr Laeger. 1995;157:3741-3745.
38. Schroll M, Hansen B, Hansen U, Kirchhoff M, Quitzau S, Eriksen LS, Stummann B, Madsen M. Myokardieinfarktincidensen i Danmark: resultater fra Dan-Monica 1982-1984. [The incidence of myocardial infarction: results from the Dan-MONICA studies 1982-1984]. Ugeskr Laeger. 1993;155:296-301.
39. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
40. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JP, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;20:1301-1307.
41. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington diabetes survey. Lancet. 1988;2:530-533.
42. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990; 300:297-300.
43. Gorgels WJMJ, van der Graaf Y, Hjemdahl P, Kortlandt W, Collette HJA, Erkelens DW, Banga J-D. Urinary excretions of high molecular weight β-thromboglobulin and albumin are independently associated with coronary heart disease in women in the Diagnostisch Onderzoek Mammacarcinom (DOM) Cohort, Utrecht, Netherlands. Am J Epidemiol. 1995;142:1157-1164.
44. Mogensen CE, Chachati A, Christensen CK, Close CF, Decken T, Hommel E, Kastrup J, Lefevre P, Mathiesen ER, Feldt-Rasmussen B. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest. 1986;9:85-95.
45. Mykkänen L, Haffner SM, Kuusisto J, Pyorälä K. Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes. 1994;43: 552-557.
46. Stender S, Zilversmit DB. Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. Arteriosclerosis. 1981;1:38-49.
47. Nordestgaard BG, Slender S,. Kjeldsen K. Reduced atherogenesis in cholesterol-fed diabetic rabbits: giant lipoproteins do not enter the arterial wall. Arteriosclerosis. 1988;8:421-428.
48. Viberti GJ, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos, A, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus. Lancet. 1982;1:1430-1432.
49. Jensen JS, Clausen P, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Detecting microalbuminuria by urinary albumin/creatinine concentration ratio. Nephrol Dial Transplant. 1997;12(suppl 2):6-9.
50. Feldt-Rasmussen B, Mathiesen ER. Variability of urinary albumin excretion in incipient diabetic nephropathy. Diab Nephrop. 1984;3: 101-103.
51. Cohen DL, Close CF, Viberti GC. The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabet Med. 1987;4:437-440.
52. Jensen JS. Intra-individual variation of overnight albumin excretion in clinically healthy middle aged individuals. Clin Chim Acta. 1995;243:95-99.
53. Ermann A, Rabinov M, Rosenfeld J. Albumin determination in frozen urines: underestimated results. Clin Chim Acta. 1988;174:255-262.
54. Jensen JS. The distribution of urinary albumin excretion and its association to atherosclerotic risk factors: a cross-sectional study of 2613 individuals. [(PhD thesis]. Copenhagen, Denmark: Faculty of Health Sciences. University of Copenhagen, Denmark; Dan Med Bull. 1996;43:379-380.